327 related articles for article (PubMed ID: 15640921)
1. The laboratory confirmation of suspected measles cases in settings of low measles transmission: conclusions from the experience in the Americas.
Dietz V; Rota J; Izurieta H; Carrasco P; Bellini W
Bull World Health Organ; 2004 Nov; 82(11):852-7. PubMed ID: 15640921
[TBL] [Abstract][Full Text] [Related]
2. Progress toward elimination of measles from the Americas.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1998 Mar; 47(10):189-93. PubMed ID: 9531021
[TBL] [Abstract][Full Text] [Related]
3. Impact of a measles elimination strategy on measles incidence in Malaysia.
Saraswathy TS; Zahrin HN; Norhashmimi H; Az-Ulhusna A; Zainah S; Rohani J
Southeast Asian J Trop Med Public Health; 2009 Jul; 40(4):742-7. PubMed ID: 19842408
[TBL] [Abstract][Full Text] [Related]
4. Recommendations from an ad hoc Meeting of the WHO Measles and Rubella Laboratory Network (LabNet) on use of alternative diagnostic samples for measles and rubella surveillance.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Jun; 57(24):657-60. PubMed ID: 18566565
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the measles clinical case definition.
Hutchins SS; Papania MJ; Amler R; Maes EF; Grabowsky M; Bromberg K; Glasglow V; Speed T; Bellini WJ; Orenstein WA
J Infect Dis; 2004 May; 189 Suppl 1():S153-9. PubMed ID: 15106104
[TBL] [Abstract][Full Text] [Related]
6. Progress toward measles eradication in the region of the Americas.
De Quadros CA; Izurieta H; Carrasco P; Brana M; Tambini G
J Infect Dis; 2003 May; 187 Suppl 1():S102-10. PubMed ID: 12721900
[TBL] [Abstract][Full Text] [Related]
7. Surveillance of measles in England and Wales: implications of a national saliva testing programme.
Ramsay M; Brugha R; Brown D
Bull World Health Organ; 1997; 75(6):515-21. PubMed ID: 9509623
[TBL] [Abstract][Full Text] [Related]
8. Measles eradication: experience in the Americas.
de Quadros CA; Hersh BS; Nogueira AC; Carrasco PA; da Silveira CM
Bull World Health Organ; 1998; 76 Suppl 2(Suppl 2):47-52. PubMed ID: 10063674
[TBL] [Abstract][Full Text] [Related]
9. Measles epidemiology and its implications for a vaccination programme in Oman.
Patel PK; Al-Awaidy ST; Bawikar S; Al-Busaidy S; Al-Mahrooqi S
East Mediterr Health J; 2008; 14(3):579-89. PubMed ID: 18720622
[TBL] [Abstract][Full Text] [Related]
10. Monitoring measles eradication in the region of the Americas: critical activities and tools.
Izurieta H; Venczel L; Dietz V; Tambini G; Barrezueta O; Carrasco P; Quiroga R; André J; Castillo-Solórzano C; Brana M; Laender F; de Quadros CA
J Infect Dis; 2003 May; 187 Suppl 1():S133-9. PubMed ID: 12721904
[TBL] [Abstract][Full Text] [Related]
11. Investigation of measles IgM-seropositive cases of febrile rash illnesses in the absence of documented measles virus transmission, State of São Paulo, Brazil, 2000-2004.
Ciccone FH; Carvalhanas TR; Afonso AM; Flannery B; Waldman EA
Rev Soc Bras Med Trop; 2010; 43(3):234-9. PubMed ID: 20563487
[TBL] [Abstract][Full Text] [Related]
12. Can measles be eradicated globally?
de Quadros CA
Bull World Health Organ; 2004 Feb; 82(2):134-8. PubMed ID: 15042236
[TBL] [Abstract][Full Text] [Related]
13. Measles eradication in the Americas: progress to date.
de Quadros CA; Izurieta H; Venczel L; Carrasco P
J Infect Dis; 2004 May; 189 Suppl 1():S227-35. PubMed ID: 15106116
[TBL] [Abstract][Full Text] [Related]
14. Expansion of the global measles and rubella laboratory network 2005-09.
Featherstone DA; Rota PA; Icenogle J; Mulders MN; Jee Y; Ahmed H; de Filippis AM; Ramamurty N; Gavrilin E; Byabamazima C; Dosseh A; Xu W; Komase K; Tashiro M; Brown D; Bellini WJ; Strebel P
J Infect Dis; 2011 Jul; 204 Suppl 1():S491-8. PubMed ID: 21666205
[TBL] [Abstract][Full Text] [Related]
15. Progress in measles and rubella elimination in Iran.
Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
[TBL] [Abstract][Full Text] [Related]
16. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance.
Pistol A; Hennessey K; Pitigoi D; Ion-Nedelcu N; Lupulescu E; Walls L; Bellini W; Strebel P
J Infect Dis; 2003 May; 187 Suppl 1():S217-22. PubMed ID: 12721916
[TBL] [Abstract][Full Text] [Related]
17. Progress toward interrupting indigenous measles transmission--Region of the Americas, January 1999-September 2000.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Nov; 49(43):986-90. PubMed ID: 11098862
[TBL] [Abstract][Full Text] [Related]
18. [Short communication: The sensitivity of measles diagnosis by physicians and families during an intraepidemic period in Edirne: implications for measles surveillance].
Eskiocak M; Ekuklu G; Doğaner E; Yilmaz N; Saltik A
Mikrobiyol Bul; 2008 Jan; 42(1):143-8. PubMed ID: 18444573
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of rubella IgM enzyme immunoassays.
Tipples GA; Hamkar R; Mohktari-Azad T; Gray M; Ball J; Head C; Ratnam S
J Clin Virol; 2004 Jul; 30(3):233-8. PubMed ID: 15135741
[TBL] [Abstract][Full Text] [Related]
20. Global measles elimination efforts: the significance of measles elimination in the United States.
Strebel PM; Henao-Restrepo AM; Hoekstra E; Olive JM; Papania MJ; Cochi SL
J Infect Dis; 2004 May; 189 Suppl 1():S251-7. PubMed ID: 15106119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
